The EPO published patent EP4645339A1 for Mentis Care, Inc., covering a seizure management system and method. The technology utilizes neural networks (G06N 3/0464, G06N 3/08, G06N 20/00) for processing biometric data including EEG signals (A61B 5/318, A61B 5/369) to detect and manage seizures. The patent is classified under health informatics (G16H 50/50, G16H 50/30) and is designated for all EU member states plus Switzerland, Norway, Turkey, and other European countries.

This patent publication represents a routine intellectual property grant by the EPO with no direct regulatory compliance obligations. Medical device companies and healthcare providers developing similar seizure detection technologies should review the patent claims to assess potential licensing needs or design-around considerations. The patent has no associated compliance deadlines or penalties as it does not impose regulatory requirements.